Hoth Therapeutics, Inc (HOTH) Stock Price

1.82 ▲ +0.22 (+13.75%)
Open: 1.67 Vol: 2.87M Day's range: 1.655 - 1.87 Sep 15, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
HOTH Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 1.81▲ 1.83▼ 1.82▲ 1.62▲ 1.44▲
MA10 1.81▲ 1.80▲ 1.74▲ 1.48▲ 1.35▲
MA20 1.83▼ 1.72▲ 1.68▲ 1.37▲ 1.23▲
MA50 1.78▲ 1.64▲ 1.54▲ 1.34▲ 1.08▲
MA100 1.70▲ 1.51▲ 1.40▲ 1.19▲ 1.10▲
MA200 1.62▲ 1.39▲ 1.34▲ 1.11▲ 4.54▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.005▼ 0.006▲ 0.014▲ 0.052▲ 0.048▲
RSI 54.589▲ 63.535▲ 69.295▲ 79.254▲ 68.166▲
STOCH 38.846     77.262     87.065▲ 82.424▲ 49.789    
WILL %R -62.500     -18.519▲ -15.625▲ -7.042▲ -6.494▲
CCI 0.000     67.094     86.594     162.849▲ 278.462▲
Latest Filters Detected On HOTH
▲ GAP $HOTH Open Gap Up %3 Set Alert
▲ GAP $HOTH Open Gap Up %2 Set Alert
▲ BREAK $HOTH Price Breaks 60 Days High Set Alert
▲ BREAK $HOTH Price Breaks 30 Days High Set Alert
▲ BREAK $HOTH Price Breaks 20 Days High Set Alert
▲ BREAK $HOTH Price Breaks 10 Days High Set Alert
Hoth Therapeutics, Inc News
Hoth Therapeutics Faces Digital Asset Industry Challenges
Friday, September 12, 2025 05:48 AM
Hoth Therapeutics ( (HOTH) ) has provided an announcement. The digital assets industry is experiencing rapid changes in technology, adoption rates, and regulatory environments, which may impact the ...
Hoth Therapeutics, Inc.: Hoth Therapeutics Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi ...
Wednesday, September 10, 2025 07:47 AM
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, today announced it has submitted ...
Hoth Therapeutics Secures Key European Regulatory Milestone with EMA Submission for Phase II Trial of HT-001 in Cancer Patients Suffering from EGFRi-Induced Skin Toxicities
Wednesday, September 10, 2025 06:55 AM
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, today announced it has submitted its Clinical Trial Application (CTA) to the European Medicines Agency (EMA) to ...
HOTH historical stock data
date open high low close volume
15/09/25 1.67 1.87 1.655 1.82 2,870,330
12/09/25 1.67 1.70 1.53 1.60 2,789,208
11/09/25 1.7004 1.80 1.59 1.60 1,873,007
10/09/25 1.45 1.62 1.40 1.61 1,607,467
09/09/25 1.46 1.50 1.44 1.46 552,800
08/09/25 1.33 1.52 1.33 1.47 2,156,065
05/09/25 1.31 1.3682 1.31 1.33 578,536
04/09/25 1.33 1.38 1.30 1.34 1,691,580
03/09/25 1.255 1.36 1.21 1.33 2,809,500
02/09/25 1.28 1.427 1.23 1.28 20,161,400
Quote Details
52wk Low:0.651
52wk High:3.775
Vol:2.87M
Avg Vol(3m):16.7M
1Y Chng:+106.82%
1M Chng:+30.00%
Add to Watch List
More Information
Index US Composite
Market Cap. 21.21M